AHNS05
NEUTROPHIL TO LYMPHOCYTE RATIO AND PERIPHERAL BLOOD BIOMARKERS CORRELATE WITH OUTCOMES AMONG PATIENTS WITH RECURRENT METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA AND SALIVARY GLAND CANCER TREATED ON A PHASE II TRIAL OF PEMBROLIZUMAB AND VORINOSTAT
Immunotherapy / Systemic Therapy
Cassie Pan1; Qian (Vicky) Wu2; Jenna Voutsinas2; Jeffrey J Houlton1; Brittany Barber1; Neal Futran1; Renato G Martins3; Jonathan R Fromm4; Cristina P Rodriguez3
1Department of Otolaryngology, University of Washington, Seattle, WA; 2Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; 3Division of Oncology, Department of Medicine, University of Washington, Seattle, WA; 4Department of Laboratory Medicine, University of Washington, Seattle, WA
AHNS09
EFFECT OF PREOPERATIVE IMMUNOTHERAPY ON COMPLICATIONS AFTER HEAD AND NECK SURGERY
Ramez Philips, MD; Angela Alnemri; Adam Luginbuhl, MD; David Cognetti, MD; Joseph Curry, MD
Thomas Jefferson University Hospitals
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX